

T6565 · 1 x 106 cells / 1.0 mL
abm good · Cat: T6565
Reach 3+ verified distributors
Manufacturer product page
abmgood.com/mavs-crispr-knockout-a549-stable-cell-line-t6565...
Description
MAVS CRISPR Knockout A549 Stable Cell Line is a human lung adenocarcinoma cell line engineered using CRISPR/Cas9 technology to disrupt the expression of MAVS Mitochondrial Antiviral Signaling protein . MAVS plays a central role in the innate immune response to viral infection by mediating downstream signaling from RIG-I and MDA5 sensors, ultimately leading to type I interferon IFN-I production. This stable knockout line offers a powerful platform for studying viral immunity, host-pathogen interactions, and innate immune escape mechanisms.







